Search Results for: MANAGEMENT INSIGHT Pharmaceutical Innovation in
Articles
MANAGEMENT INSIGHT - Pharmaceutical Innovation in the Second Machine Age January 7, 2015
Derek Hennecke says on one side, we have those who argue that technology is advancing so fast we have achieved a second-derivative rate of change. On the other side are those who claim we haven’t seen true innovation since the 1970s. Which is it?
SPECIAL FEATURE - PFS & Parenteral Delivery: Innovation Is Focused on Patient-Centric, Smart & Sustainable Solutions May 7, 2025
Contributor Cindy H. Dubin speaks with several innovating companies to discuss trends in PFS as well as advancements in autoinjectors and innovations in parenteral delivery.
EXECUTIVE INTERVIEW - How Vetter’s Expansion of its Senior Management Team Aligns With Prioritization of Strategic Growth April 3, 2025
Vetter’s leadership discusses the company’s vision for strategic restructuring, their insights on Contract Development and Manufacturing trends in 2025, and what this strategic change means for the sustainable growth of the company and its global expansion.
OUTSOURCING PHARMA DEVELOPMENT - Harnessing CDMOs for Innovation & Efficiency February 10, 2025
Rohtash Kumar, PhD, says a strategic partnership with a trusted CDMO can provide many benefits ranging from experts’ insights to state-of-the-art equipment. However, there are several considerations that developers should evaluate prior to engaging with a CDMO to maximize their partnership.
Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use AI & Cybernetics December 12, 2024
Conduit Pharmaceuticals Inc. recently announced it has entered into an agreement with SARBORG Limited to leverage an advanced artificial intelligence...Bormioli Pharma Invents The Open & Collaborative Innovation Platform for the Pharmaceutical Packaging of the Future November 22, 2024
Bormioli Pharma, a global leader in the production of containers for pharmaceutical use and medical devices, has always been a...MARKET REPORT - Survey Suggests Global Innovation to Recover Much More Quickly Than Expected in 2023 February 9, 2023
After a brief fall in 2022 to a score of 6.5 – the first decline since its inception in 2018 – the index has surged to a record score of 7.4. This sudden recovery in scores over a little more than 8 months bodes extremely well for device and packaging manufacturers in the year ahead, suggesting a strong global recovery in industry outlook and confidence.
DATA STRATEGIES - As We Shift Toward Biologics, We Also Need to Shift Toward Smarter Data Management March 1, 2022
Christian Marcazzo explains how adopting a new kind of data strategy might be disruptive to the expectation of how biologics development is carried out — but it may also be transformational.
ASLAN Pharmaceuticals & IQVIA Biotech Enter Strategic Collaboration December 6, 2021
ASLAN Pharmaceuticals recently announced the appointment of IQVIA Biotech, a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, as its preferred….
SPECIAL FEATURE - Prefilled Syringes & Parenteral Manufacturing: Innovations, Challenges & Solutions May 5, 2020
Contributor Cindy H. Dubin features several leading companies’ innovations in delivery devices as well as how contract parenteral manufacturers are addressing the ever-demanding challenges, issues, and opportunities related to delivering biologics and small molecules.
EXECUTIVE INTERVIEW - Vetter: Insights on Insourcing Versus Outsourcing in the World of Injectable Manufacturing January 8, 2019
Oskar Gold, Vetter’s Senior VP, Key Account Management and Marketing/Corporate Communications, offers his insights on aseptic manufacturing and why careful thought and consideration of different criteria must be applied.
Sienna Biopharmaceuticals Announces First Patient Dosed in Proof-of-Concept Trial March 20, 2018
Sienna Biopharmaceuticals, Inc. recently announced that the first patient has been dosed in the company’s Phase 1/2 proof-of-concept clinical trial...Daiichi Sankyo, Max Planck Innovation and Lead Discovery Center Announce Cancer Research Collaboration July 11, 2017
Daiichi Sankyo Co., Limited (hereafter, Daiichi Sankyo), Max Planck Innovation GmbH and the Lead Discovery Center GmbH have signed an...CONTRACT MANUFACTURING - Delivering Market Success & ROI to Pharmaceutical Partners May 31, 2017
Mike Schaefers, PhD, and Mike Treadaway say more than ever, contract manufacturing must deliver continuous innovation and flexibility to accommodate the delivery of a wide range of drugs throughout each therapy’s lifecycle.
EXECUTIVE INTERVIEW - Cronos: Innovation in Clinical Trial Services Through Focus on Quality Data September 2, 2014
Drug Development Executive: Guillermo DiClemente, Founder & President of Cronos Clinical Consulting Service, discusses the company’s unique approach, its relationship with customers, industry trends, and the importance of focusing on quality clinical data.
MANAGEMENT INSIGHT - The Davids of Drug Development September 2, 2014
Derek Hennecke believes every one of us is a little guy, facing insurmountable odds, scouring the countless compounds of the universe in search of a cure. Most of them sizzle and die out. And yet we move on, like addicts in search of a buzz, pursuing that moment again; that one incredible high that is drug discovery.
MANAGEMENT INSIGHT - The Biotech Bubble: What Goes Up Must Come Down May 6, 2014
Physicists know it. Coffee drinkers live it. Roller coasters capitalize on it. Yet stock market investors - even coffee-drinking physicist-investors...EXECUTIVE INTERVIEW - Vetter: Successfully Bridging the Innovation Gap in Drug Development & Manufacturing September 5, 2013
BIOGRAPHY Claudia Roth, PhD President, Vetter Development Service Chicago “We are noticing that CDMOs are acting more and more as...MANAGEMENT INSIGHT - Lessons From the Auto Industry July 10, 2013
Derek G. Hennecke concludes his 6-part series offering an overview of this year’s best business books with insights into what they can teach the Pharma industry.
EXECUTIVE INTERVIEW - SNBL, Ltd.: Innovation in Drug Delivery Enabled Through a Unique Business Model April 30, 2013
Drug Development Executive: Dr. Shunji Haruta, Founder of NDS (Nasal Delivery Systems) Division and Executive Officer, SNBL, Ltd., discusses how NDS Division and its powder nasal delivery platform, µco System, fit into a new paradigm.
